Literature DB >> 16297087

Quality of life in Brazilian breast cancer survivors age 45-65 years: associated factors.

Délio Marques Conde1, Aarão Mendes Pinto-Neto, César Cabello, Danielle Santos-Sá, Lúcia Costa-Paiva, Edson Zangiacomi Martinez.   

Abstract

The objectives of this study were to evaluate quality of life (QOL) and identify its associated factors in climacteric women with a history of breast cancer. A cross-sectional study was performed including 75 breast cancer survivors age 45-65 years who had undergone complete oncologic treatment and nonusers of hormone therapy or tamoxifen in the last 6 months. Sociodemographic and clinical characteristics in addition to the prevalence of climacteric symptoms were evaluated. QOL was evaluated by the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) questionnaire, including eight components that can be condensed into two summaries: a physical component summary (physical functioning, role-physical, body pain, general health) and a mental component summary (vitality, social functioning, role-emotional, and mental health). Generalized linear models were used to analyze the data, allowing the identification of factors affecting QOL, adjusting for confounding variables. The mean age of the participants was 53.1+/-5.9 years. Breast cancer survivors reported good QOL. The most prevalent symptoms were nervousness (69%) and hot flashes (56%). Factors associated with poorer QOL were dizziness, postmenopausal status, and breast-conserving therapy (physical component), as well as insomnia and being married (mental component). In conclusion, participants demonstrated good QOL. We identified factors that may influence QOL in women with breast cancer, highlighting being married, climacteric symptoms, postmenopausal status, and breast-conserving therapy. Given the impact of these factors, health professionals and patients must discuss choices for alleviating climacteric symptoms and explanations for the potential repercussions of breast cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297087     DOI: 10.1111/j.1075-122X.2005.00124.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  9 in total

1.  Sexual function and sex hormones in breast cancer patients.

Authors:  Antonio Gambardella; Daniela Esposito; Giacomo Accardo; Marianna Taddeo; Antonietta Letizia; Rossella Tagliafierro; Katherine Esposito; Daniela Pasquali
Journal:  Endocrine       Date:  2017-11-14       Impact factor: 3.633

2.  Comparison of quality of life, satisfaction with surgery and shoulder-arm morbidity in breast cancer survivors submitted to breast-conserving therapy or mastectomy followed by immediate breast reconstruction.

Authors:  Renata Freitas-Silva; Délio Marques Conde; Ruffo de Freitas-Júnior; Edson Zangiacomi Martinez
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

3.  Low Bone Mineral Density in Middle-Aged Breast Cancer Survivors: Prevalence and Associated Factors.

Authors:  Délio Marques Conde; Lúcia Costa-Paiva; Edson Zangiacomi Martinez; Aarão Mendes Pinto-Neto
Journal:  Breast Care (Basel)       Date:  2012-04-23       Impact factor: 2.860

4.  Quality of life as a predictor of overall survival after breast cancer treatment.

Authors:  Suzana Sales De Aguiar; Anke Bergmann; Inês Echenique Mattos
Journal:  Qual Life Res       Date:  2013-07-20       Impact factor: 4.147

5.  Effect of Agaricus sylvaticus supplementation on nutritional status and adverse events of chemotherapy of breast cancer: a randomized, placebo-controlled, double-blind clinical trial.

Authors:  Fabiana Valadares; Maria Rita Carvalho Garbi Novaes; Roberto Cañete
Journal:  Indian J Pharmacol       Date:  2013 May-Jun       Impact factor: 1.200

6.  Patient-Reported Outcomes Are Better after Oncoplastic Breast Conservation than after Mastectomy and Autologous Reconstruction.

Authors:  Natalie D Chand; Victoria Browne; Nirmala Paramanathan; Lashan J Peiris; Siobhan A Laws; Richard M Rainsbury
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-07-24

7.  Symptoms in long-term breast cancer survivors: A cross-sectional study in primary care.

Authors:  S W M C Maass; L M Boerman; D Brandenbarg; P F M Verhaak; J H Maduro; G H de Bock; A J Berendsen
Journal:  Breast       Date:  2020-09-30       Impact factor: 4.380

8.  The influence of a supervised group exercise intervention combined with active lifestyle recommendations on breast cancer survivors' health, physical functioning, and quality of life indices: study protocol for a randomized and controlled trial.

Authors:  Luiz Augusto Riani Costa; Raphael F Barreto; Sarah Milani Moraes de Leandrini; Aline Rachel Bezerra Gurgel; Gabriel Toledo de Sales; Vanessa Azevedo Voltarelli; Gilberto de Castro; Sally A M Fenton; James E Turner; Christian Klausener; Lucas Melo Neves; Carlos Ugrinowitsch; Jose Carlos Farah; Cláudia Lúcia de Moraes Forjaz; Christina May Moran Brito; Patricia Chakur Brum
Journal:  Trials       Date:  2021-12-18       Impact factor: 2.279

9.  Sexual function and chemotherapy in postmenopausal women with breast cancer.

Authors:  José Antônio Crespo Cavalheiro; Anacristinadacosta Bittelbrunn; Carlos Henrique Menke; Jorge Villanova Biazús; Nilton Leite Xavier; Rodrigo Cericatto; Fernando Schuh; Caroline Vieira Pinheiro; Eduardo Pandolfi Passos
Journal:  BMC Womens Health       Date:  2012-09-11       Impact factor: 2.809

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.